NO20035138D0 - Fremgangsmåte til fremstilling av amorft natriumsilastatin - Google Patents

Fremgangsmåte til fremstilling av amorft natriumsilastatin

Info

Publication number
NO20035138D0
NO20035138D0 NO20035138A NO20035138A NO20035138D0 NO 20035138 D0 NO20035138 D0 NO 20035138D0 NO 20035138 A NO20035138 A NO 20035138A NO 20035138 A NO20035138 A NO 20035138A NO 20035138 D0 NO20035138 D0 NO 20035138D0
Authority
NO
Norway
Prior art keywords
silastatin
preparation
amorphous sodium
amorphous
sodium
Prior art date
Application number
NO20035138A
Other languages
English (en)
Inventor
Yatendra Kumar
Om Dutt Tyagi
Amit Rohtagi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of NO20035138D0 publication Critical patent/NO20035138D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/04Methanol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
NO20035138A 2001-05-18 2003-11-18 Fremgangsmåte til fremstilling av amorft natriumsilastatin NO20035138D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN593DE2001 2001-05-18
PCT/IB2002/001696 WO2002094742A1 (en) 2001-05-18 2002-05-17 Process for the preparation of amorphous cilastatin sodium

Publications (1)

Publication Number Publication Date
NO20035138D0 true NO20035138D0 (no) 2003-11-18

Family

ID=11097060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035138A NO20035138D0 (no) 2001-05-18 2003-11-18 Fremgangsmåte til fremstilling av amorft natriumsilastatin

Country Status (24)

Country Link
US (1) US20040152780A1 (no)
EP (1) EP1395530A4 (no)
JP (1) JP2004526805A (no)
KR (1) KR20040044409A (no)
CN (1) CN1522235A (no)
AP (2) AP2003002912A0 (no)
AR (1) AR036017A1 (no)
BG (1) BG108447A (no)
BR (1) BR0209843A (no)
CA (1) CA2447788A1 (no)
CZ (1) CZ20033352A3 (no)
EA (1) EA005947B1 (no)
EE (1) EE200300567A (no)
HR (1) HRP20031052A2 (no)
HU (1) HUP0400825A2 (no)
IL (1) IL158945A0 (no)
MX (1) MXPA03010547A (no)
NO (1) NO20035138D0 (no)
NZ (1) NZ529625A (no)
OA (1) OA12607A (no)
PL (1) PL367937A1 (no)
SK (1) SK15082003A3 (no)
WO (1) WO2002094742A1 (no)
ZA (1) ZA200309287B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8134026B2 (en) * 2005-11-09 2012-03-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of Cilastatin and sodium salt
WO2011080648A1 (en) * 2010-01-01 2011-07-07 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of cilastatin sodium
CN102675175B (zh) * 2011-03-08 2014-02-19 深圳市海滨制药有限公司 一种西司他丁的分离纯化方法
US11324804B2 (en) 2016-11-18 2022-05-10 Sepsia Therapeutics, S.L. Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
EP0441371B1 (en) * 1990-02-08 1995-01-25 Sumitomo Chemical Company, Limited Process for preparing haloketo acid derivatives
US5166417A (en) * 1990-09-04 1992-11-24 Lonza Ltd. Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
CA2056840A1 (en) * 1990-12-17 1992-06-18 Thomas Meul Process for the production of dimethylcyclopropanecarboxylic acid
EP0524604B1 (de) * 1991-07-26 1998-10-14 Lonza A.G. Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (no) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ZA200309287B (en) 2004-07-22
AP2003002913A0 (en) 2003-12-31
EP1395530A4 (en) 2006-01-18
AR036017A1 (es) 2004-08-04
KR20040044409A (ko) 2004-05-28
AP2003002912A0 (en) 2002-05-17
EP1395530A1 (en) 2004-03-10
MXPA03010547A (es) 2004-05-27
US20040152780A1 (en) 2004-08-05
BR0209843A (pt) 2004-08-24
IL158945A0 (en) 2004-05-12
AP1511A (en) 2005-12-20
HRP20031052A2 (en) 2004-06-30
NZ529625A (en) 2006-02-24
SK15082003A3 (sk) 2004-06-08
BG108447A (en) 2005-03-31
JP2004526805A (ja) 2004-09-02
EA005947B1 (ru) 2005-08-25
PL367937A1 (en) 2005-03-07
EE200300567A (et) 2004-04-15
OA12607A (en) 2006-06-08
HUP0400825A2 (hu) 2004-08-30
CA2447788A1 (en) 2002-11-28
CN1522235A (zh) 2004-08-18
EA200301225A1 (ru) 2004-06-24
WO2002094742A1 (en) 2002-11-28
CZ20033352A3 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
NO20013943D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20034003D0 (no) Fremgangsmåte for fremstilling av imidazol-forbindelser
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20025703L (no) Fremgangsmåte for fremstilling av vannfritt natriumperklorat
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20040485L (no) Fremgangsmåte til fremstilling av amorf form av torsemid.
NO20041193L (no) Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application